nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—liver cancer	0.137	0.519	CrCtD
Daunorubicin—Doxorubicin—liver cancer	0.127	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—liver cancer	0.11	0.341	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—liver cancer	0.102	0.316	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—liver cancer	0.0576	0.178	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—liver cancer	0.0533	0.165	CiPCiCtD
Daunorubicin—YWHAG—Epirubicin—liver cancer	0.0441	0.309	CbGbCtD
Daunorubicin—CYP1A1—liver cancer	0.0426	1	CbGaD
Daunorubicin—Doxorubicin—Epirubicin—liver cancer	0.0294	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—liver cancer	0.0294	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—liver cancer	0.0294	0.173	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—liver cancer	0.0272	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—liver cancer	0.0272	0.16	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—liver cancer	0.0272	0.16	CrCrCtD
Daunorubicin—YWHAG—Doxorubicin—liver cancer	0.0235	0.164	CbGbCtD
Daunorubicin—POR—Doxorubicin—liver cancer	0.00974	0.0682	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—liver cancer	0.00897	0.0628	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—liver cancer	0.00895	0.0627	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—liver cancer	0.00684	0.0479	CbGbCtD
Daunorubicin—ABCB11—bile canaliculus—liver cancer	0.00627	0.386	CbGeAlD
Daunorubicin—XDH—Doxorubicin—liver cancer	0.00559	0.0392	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—liver cancer	0.00497	0.0348	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—liver cancer	0.00476	0.0333	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—liver cancer	0.00372	0.026	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—liver cancer	0.00372	0.026	CbGbCtD
Daunorubicin—ABCC2—Sorafenib—liver cancer	0.00322	0.0226	CbGbCtD
Daunorubicin—ABCC2—bile canaliculus—liver cancer	0.00319	0.196	CbGeAlD
Daunorubicin—ABCG2—Sorafenib—liver cancer	0.00291	0.0204	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—liver cancer	0.00264	0.0185	CbGbCtD
Daunorubicin—ABCB11—bile duct—liver cancer	0.00196	0.121	CbGeAlD
Daunorubicin—ABCC2—Doxorubicin—liver cancer	0.00195	0.0137	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—liver cancer	0.00177	0.0124	CbGbCtD
Daunorubicin—CYP3A5—Sorafenib—liver cancer	0.00161	0.0113	CbGbCtD
Daunorubicin—ABCB11—bile—liver cancer	0.0015	0.0928	CbGeAlD
Daunorubicin—CYP1A2—Sorafenib—liver cancer	0.0012	0.00841	CbGbCtD
Daunorubicin—ABCB1—Sorafenib—liver cancer	0.00105	0.00735	CbGbCtD
Daunorubicin—ABCC2—bile duct—liver cancer	0.000996	0.0614	CbGeAlD
Daunorubicin—ABCC2—bile—liver cancer	0.000765	0.0472	CbGeAlD
Daunorubicin—ABCB1—Doxorubicin—liver cancer	0.000637	0.00446	CbGbCtD
Daunorubicin—CYP3A4—Sorafenib—liver cancer	0.000629	0.0044	CbGbCtD
Daunorubicin—CYP3A4—Doxorubicin—liver cancer	0.000382	0.00267	CbGbCtD
Daunorubicin—TOP2B—embryo—liver cancer	0.000268	0.0165	CbGeAlD
Daunorubicin—ABCC6—liver—liver cancer	0.000137	0.00842	CbGeAlD
Daunorubicin—YWHAG—liver—liver cancer	0.000129	0.00792	CbGeAlD
Daunorubicin—XDH—liver—liver cancer	0.000125	0.00773	CbGeAlD
Daunorubicin—TOP2B—liver—liver cancer	0.000124	0.00764	CbGeAlD
Daunorubicin—ABCB11—liver—liver cancer	0.000122	0.00755	CbGeAlD
Daunorubicin—POR—liver—liver cancer	9.77e-05	0.00603	CbGeAlD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—liver cancer	9.19e-05	0.26	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—liver cancer	9.19e-05	0.26	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—liver cancer	8.51e-05	0.24	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—liver cancer	8.51e-05	0.24	CbGdCrCtD
Daunorubicin—ABCC10—liver—liver cancer	7.76e-05	0.00478	CbGeAlD
Daunorubicin—ABCC2—liver—liver cancer	6.23e-05	0.00384	CbGeAlD
Daunorubicin—Ventricular extrasystoles—Epirubicin—liver cancer	6.14e-05	0.00271	CcSEcCtD
Daunorubicin—CYP1B1—liver—liver cancer	6.1e-05	0.00376	CbGeAlD
Daunorubicin—Cellulitis—Epirubicin—liver cancer	6.09e-05	0.00269	CcSEcCtD
Daunorubicin—Anaemia—Sorafenib—liver cancer	6.06e-05	0.00268	CcSEcCtD
Daunorubicin—Thinking abnormal—Epirubicin—liver cancer	6.05e-05	0.00267	CcSEcCtD
Daunorubicin—Nocturia—Epirubicin—liver cancer	5.97e-05	0.00264	CcSEcCtD
Daunorubicin—Hyperuricaemia—Epirubicin—liver cancer	5.97e-05	0.00264	CcSEcCtD
Daunorubicin—Syncope—Sorafenib—liver cancer	5.88e-05	0.0026	CcSEcCtD
Daunorubicin—Extravasation—Doxorubicin—liver cancer	5.88e-05	0.00259	CcSEcCtD
Daunorubicin—Leukopenia—Sorafenib—liver cancer	5.87e-05	0.00259	CcSEcCtD
Daunorubicin—Ulcer—Epirubicin—liver cancer	5.86e-05	0.00259	CcSEcCtD
Daunorubicin—Loss of consciousness—Sorafenib—liver cancer	5.76e-05	0.00254	CcSEcCtD
Daunorubicin—Cough—Sorafenib—liver cancer	5.72e-05	0.00253	CcSEcCtD
Daunorubicin—Atrioventricular block—Epirubicin—liver cancer	5.71e-05	0.00252	CcSEcCtD
Daunorubicin—Gait disturbance—Epirubicin—liver cancer	5.68e-05	0.00251	CcSEcCtD
Daunorubicin—Ventricular extrasystoles—Doxorubicin—liver cancer	5.68e-05	0.00251	CcSEcCtD
Daunorubicin—Viral infection—Doxorubicin—liver cancer	5.68e-05	0.00251	CcSEcCtD
Daunorubicin—Hypertension—Sorafenib—liver cancer	5.66e-05	0.0025	CcSEcCtD
Daunorubicin—Blood uric acid increased—Epirubicin—liver cancer	5.64e-05	0.00249	CcSEcCtD
Daunorubicin—Cellulitis—Doxorubicin—liver cancer	5.64e-05	0.00249	CcSEcCtD
Daunorubicin—Thinking abnormal—Doxorubicin—liver cancer	5.6e-05	0.00247	CcSEcCtD
Daunorubicin—Myalgia—Sorafenib—liver cancer	5.58e-05	0.00246	CcSEcCtD
Daunorubicin—Arthralgia—Sorafenib—liver cancer	5.58e-05	0.00246	CcSEcCtD
Daunorubicin—Hiccups—Epirubicin—liver cancer	5.54e-05	0.00245	CcSEcCtD
Daunorubicin—Hyperuricaemia—Doxorubicin—liver cancer	5.53e-05	0.00244	CcSEcCtD
Daunorubicin—Nocturia—Doxorubicin—liver cancer	5.53e-05	0.00244	CcSEcCtD
Daunorubicin—ABCC1—liver—liver cancer	5.49e-05	0.00338	CbGeAlD
Daunorubicin—Dermatitis contact—Epirubicin—liver cancer	5.48e-05	0.00242	CcSEcCtD
Daunorubicin—Dry mouth—Sorafenib—liver cancer	5.46e-05	0.00241	CcSEcCtD
Daunorubicin—Ulcer—Doxorubicin—liver cancer	5.42e-05	0.00239	CcSEcCtD
Daunorubicin—Melaena—Epirubicin—liver cancer	5.41e-05	0.00239	CcSEcCtD
Daunorubicin—Influenza like illness—Epirubicin—liver cancer	5.38e-05	0.00238	CcSEcCtD
Daunorubicin—Anaphylactic shock—Sorafenib—liver cancer	5.35e-05	0.00236	CcSEcCtD
Daunorubicin—Infection—Sorafenib—liver cancer	5.31e-05	0.00235	CcSEcCtD
Daunorubicin—Atrioventricular block—Doxorubicin—liver cancer	5.29e-05	0.00233	CcSEcCtD
Daunorubicin—Shock—Sorafenib—liver cancer	5.26e-05	0.00232	CcSEcCtD
Daunorubicin—Gait disturbance—Doxorubicin—liver cancer	5.25e-05	0.00232	CcSEcCtD
Daunorubicin—Thrombocytopenia—Sorafenib—liver cancer	5.24e-05	0.00231	CcSEcCtD
Daunorubicin—Blood uric acid increased—Doxorubicin—liver cancer	5.22e-05	0.00231	CcSEcCtD
Daunorubicin—Neuropathy—Epirubicin—liver cancer	5.2e-05	0.0023	CcSEcCtD
Daunorubicin—Hiccups—Doxorubicin—liver cancer	5.13e-05	0.00226	CcSEcCtD
Daunorubicin—Anorexia—Sorafenib—liver cancer	5.1e-05	0.00225	CcSEcCtD
Daunorubicin—Dermatitis contact—Doxorubicin—liver cancer	5.07e-05	0.00224	CcSEcCtD
Daunorubicin—Oesophagitis—Epirubicin—liver cancer	5.06e-05	0.00224	CcSEcCtD
Daunorubicin—Melaena—Doxorubicin—liver cancer	5.01e-05	0.00221	CcSEcCtD
Daunorubicin—Influenza like illness—Doxorubicin—liver cancer	4.98e-05	0.0022	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Sorafenib—liver cancer	4.87e-05	0.00215	CcSEcCtD
Daunorubicin—Hypertonia—Epirubicin—liver cancer	4.86e-05	0.00214	CcSEcCtD
Daunorubicin—ABCB1—embryo—liver cancer	4.84e-05	0.00298	CbGeAlD
Daunorubicin—Abnormal vision—Epirubicin—liver cancer	4.83e-05	0.00213	CcSEcCtD
Daunorubicin—Neuropathy—Doxorubicin—liver cancer	4.81e-05	0.00213	CcSEcCtD
Daunorubicin—Mental disability—Epirubicin—liver cancer	4.81e-05	0.00212	CcSEcCtD
Daunorubicin—Dyspnoea—Sorafenib—liver cancer	4.77e-05	0.00211	CcSEcCtD
Daunorubicin—Lymphadenopathy—Epirubicin—liver cancer	4.71e-05	0.00208	CcSEcCtD
Daunorubicin—Oesophagitis—Doxorubicin—liver cancer	4.69e-05	0.00207	CcSEcCtD
Daunorubicin—Decreased appetite—Sorafenib—liver cancer	4.65e-05	0.00205	CcSEcCtD
Daunorubicin—Thrombophlebitis—Epirubicin—liver cancer	4.65e-05	0.00205	CcSEcCtD
Daunorubicin—Fatigue—Sorafenib—liver cancer	4.61e-05	0.00204	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Epirubicin—liver cancer	4.6e-05	0.00203	CcSEcCtD
Daunorubicin—Pain—Sorafenib—liver cancer	4.57e-05	0.00202	CcSEcCtD
Daunorubicin—Constipation—Sorafenib—liver cancer	4.57e-05	0.00202	CcSEcCtD
Daunorubicin—ABCG2—liver—liver cancer	4.54e-05	0.0028	CbGeAlD
Daunorubicin—Hypertonia—Doxorubicin—liver cancer	4.49e-05	0.00198	CcSEcCtD
Daunorubicin—Abnormal vision—Doxorubicin—liver cancer	4.47e-05	0.00197	CcSEcCtD
Daunorubicin—Eye pain—Epirubicin—liver cancer	4.46e-05	0.00197	CcSEcCtD
Daunorubicin—Mental disability—Doxorubicin—liver cancer	4.45e-05	0.00196	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Epirubicin—liver cancer	4.44e-05	0.00196	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Sorafenib—liver cancer	4.37e-05	0.00193	CcSEcCtD
Daunorubicin—CYP1A2—liver—liver cancer	4.37e-05	0.00269	CbGeAlD
Daunorubicin—Lymphadenopathy—Doxorubicin—liver cancer	4.36e-05	0.00193	CcSEcCtD
Daunorubicin—CYP1A1—liver—liver cancer	4.31e-05	0.00266	CbGeAlD
Daunorubicin—Hot flush—Epirubicin—liver cancer	4.3e-05	0.0019	CcSEcCtD
Daunorubicin—Thrombophlebitis—Doxorubicin—liver cancer	4.3e-05	0.0019	CcSEcCtD
Daunorubicin—Increased appetite—Epirubicin—liver cancer	4.28e-05	0.00189	CcSEcCtD
Daunorubicin—Menopausal symptoms—Epirubicin—liver cancer	4.26e-05	0.00188	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Doxorubicin—liver cancer	4.26e-05	0.00188	CcSEcCtD
Daunorubicin—Urticaria—Sorafenib—liver cancer	4.25e-05	0.00188	CcSEcCtD
Daunorubicin—Body temperature increased—Sorafenib—liver cancer	4.23e-05	0.00187	CcSEcCtD
Daunorubicin—Abdominal pain—Sorafenib—liver cancer	4.23e-05	0.00187	CcSEcCtD
Daunorubicin—Renal impairment—Epirubicin—liver cancer	4.23e-05	0.00187	CcSEcCtD
Daunorubicin—CYP3A5—liver—liver cancer	4.22e-05	0.0026	CbGeAlD
Daunorubicin—Anaphylactoid reaction—Epirubicin—liver cancer	4.16e-05	0.00184	CcSEcCtD
Daunorubicin—Eye pain—Doxorubicin—liver cancer	4.12e-05	0.00182	CcSEcCtD
Daunorubicin—Cardiac failure—Epirubicin—liver cancer	4.12e-05	0.00182	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Doxorubicin—liver cancer	4.1e-05	0.00181	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	4.02e-05	0.00178	CcSEcCtD
Daunorubicin—Hot flush—Doxorubicin—liver cancer	3.98e-05	0.00176	CcSEcCtD
Daunorubicin—Increased appetite—Doxorubicin—liver cancer	3.96e-05	0.00175	CcSEcCtD
Daunorubicin—Affect lability—Epirubicin—liver cancer	3.96e-05	0.00175	CcSEcCtD
Daunorubicin—Menopausal symptoms—Doxorubicin—liver cancer	3.94e-05	0.00174	CcSEcCtD
Daunorubicin—Hypersensitivity—Sorafenib—liver cancer	3.94e-05	0.00174	CcSEcCtD
Daunorubicin—Renal impairment—Doxorubicin—liver cancer	3.91e-05	0.00173	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—liver cancer	3.85e-05	0.0017	CcSEcCtD
Daunorubicin—Asthenia—Sorafenib—liver cancer	3.84e-05	0.00169	CcSEcCtD
Daunorubicin—Cardiac arrest—Epirubicin—liver cancer	3.82e-05	0.00169	CcSEcCtD
Daunorubicin—Cardiac failure—Doxorubicin—liver cancer	3.81e-05	0.00168	CcSEcCtD
Daunorubicin—Mood swings—Epirubicin—liver cancer	3.81e-05	0.00168	CcSEcCtD
Daunorubicin—Pruritus—Sorafenib—liver cancer	3.78e-05	0.00167	CcSEcCtD
Daunorubicin—Ataxia—Epirubicin—liver cancer	3.78e-05	0.00167	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—liver cancer	3.74e-05	0.00165	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	3.72e-05	0.00164	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—liver cancer	3.69e-05	0.00163	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—liver cancer	3.66e-05	0.00162	CcSEcCtD
Daunorubicin—Diarrhoea—Sorafenib—liver cancer	3.66e-05	0.00162	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—liver cancer	3.56e-05	0.00157	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—liver cancer	3.54e-05	0.00156	CcSEcCtD
Daunorubicin—Dizziness—Sorafenib—liver cancer	3.54e-05	0.00156	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—liver cancer	3.53e-05	0.00156	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—liver cancer	3.5e-05	0.00155	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—liver cancer	3.48e-05	0.00154	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—liver cancer	3.46e-05	0.00153	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—liver cancer	3.41e-05	0.00151	CcSEcCtD
Daunorubicin—Vomiting—Sorafenib—liver cancer	3.4e-05	0.0015	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—liver cancer	3.39e-05	0.0015	CcSEcCtD
Daunorubicin—Rash—Sorafenib—liver cancer	3.37e-05	0.00149	CcSEcCtD
Daunorubicin—Dermatitis—Sorafenib—liver cancer	3.37e-05	0.00149	CcSEcCtD
Daunorubicin—Headache—Sorafenib—liver cancer	3.35e-05	0.00148	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—liver cancer	3.3e-05	0.00146	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—liver cancer	3.29e-05	0.00145	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—liver cancer	3.25e-05	0.00144	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—liver cancer	3.25e-05	0.00144	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—liver cancer	3.22e-05	0.00142	CcSEcCtD
Daunorubicin—Nausea—Sorafenib—liver cancer	3.18e-05	0.0014	CcSEcCtD
Daunorubicin—CYP3A4—liver—liver cancer	3.16e-05	0.00195	CbGeAlD
Daunorubicin—Angina pectoris—Doxorubicin—liver cancer	3.13e-05	0.00138	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—liver cancer	3.05e-05	0.00135	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—liver cancer	3.05e-05	0.00135	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—liver cancer	3.04e-05	0.00134	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—liver cancer	3.02e-05	0.00133	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—liver cancer	3.01e-05	0.00133	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—liver cancer	3.01e-05	0.00133	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—liver cancer	3.01e-05	0.00133	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—liver cancer	2.91e-05	0.00128	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—liver cancer	2.82e-05	0.00124	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—liver cancer	2.81e-05	0.00124	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—liver cancer	2.8e-05	0.00123	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—liver cancer	2.79e-05	0.00123	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—liver cancer	2.79e-05	0.00123	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—liver cancer	2.69e-05	0.00119	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—liver cancer	2.68e-05	0.00118	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—liver cancer	2.59e-05	0.00115	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—liver cancer	2.58e-05	0.00114	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—liver cancer	2.58e-05	0.00114	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—liver cancer	2.58e-05	0.00114	CcSEcCtD
Daunorubicin—Chills—Epirubicin—liver cancer	2.5e-05	0.0011	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—liver cancer	2.49e-05	0.0011	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—liver cancer	2.48e-05	0.0011	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—liver cancer	2.46e-05	0.00109	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—liver cancer	2.42e-05	0.00107	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—liver cancer	2.4e-05	0.00106	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—liver cancer	2.39e-05	0.00106	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—liver cancer	2.39e-05	0.00106	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—liver cancer	2.37e-05	0.00105	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—liver cancer	2.34e-05	0.00103	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—liver cancer	2.31e-05	0.00102	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—liver cancer	2.3e-05	0.00102	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—liver cancer	2.28e-05	0.001	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—liver cancer	2.25e-05	0.000992	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—liver cancer	2.24e-05	0.00099	CcSEcCtD
Daunorubicin—ABCB1—liver—liver cancer	2.24e-05	0.00138	CbGeAlD
Daunorubicin—Anaemia—Epirubicin—liver cancer	2.24e-05	0.000989	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—liver cancer	2.23e-05	0.000983	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—liver cancer	2.19e-05	0.000969	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—liver cancer	2.18e-05	0.000965	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—liver cancer	2.17e-05	0.000959	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—liver cancer	2.17e-05	0.000957	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—liver cancer	2.17e-05	0.000957	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—liver cancer	2.14e-05	0.000945	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—liver cancer	2.13e-05	0.00094	CcSEcCtD
Daunorubicin—Cough—Epirubicin—liver cancer	2.11e-05	0.000933	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—liver cancer	2.1e-05	0.000927	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—liver cancer	2.09e-05	0.000923	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—liver cancer	2.08e-05	0.000918	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—liver cancer	2.07e-05	0.000915	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—liver cancer	2.06e-05	0.000911	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—liver cancer	2.06e-05	0.000911	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—liver cancer	2.06e-05	0.000911	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—liver cancer	2.06e-05	0.00091	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—liver cancer	2.06e-05	0.000907	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—liver cancer	2.04e-05	0.0009	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—liver cancer	2.02e-05	0.000893	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—liver cancer	2.02e-05	0.000891	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—liver cancer	2.01e-05	0.000888	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—liver cancer	2.01e-05	0.000886	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—liver cancer	1.99e-05	0.00088	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—liver cancer	1.98e-05	0.000875	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—liver cancer	1.98e-05	0.000873	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—liver cancer	1.98e-05	0.000873	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—liver cancer	1.97e-05	0.00087	CcSEcCtD
Daunorubicin—Infection—Epirubicin—liver cancer	1.96e-05	0.000867	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—liver cancer	1.96e-05	0.000864	CcSEcCtD
Daunorubicin—Shock—Epirubicin—liver cancer	1.95e-05	0.000859	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—liver cancer	1.94e-05	0.000858	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—liver cancer	1.94e-05	0.000855	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—liver cancer	1.94e-05	0.000854	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—liver cancer	1.93e-05	0.000852	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—liver cancer	1.91e-05	0.000844	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—liver cancer	1.91e-05	0.000843	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—liver cancer	1.91e-05	0.000843	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—liver cancer	1.91e-05	0.000843	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—liver cancer	1.9e-05	0.00084	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—liver cancer	1.89e-05	0.000832	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—liver cancer	1.88e-05	0.000832	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—liver cancer	1.87e-05	0.000824	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—liver cancer	1.84e-05	0.000814	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—liver cancer	1.83e-05	0.000808	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—liver cancer	1.83e-05	0.000808	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—liver cancer	1.82e-05	0.000802	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—liver cancer	1.8e-05	0.000795	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—liver cancer	1.8e-05	0.000795	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—liver cancer	1.79e-05	0.000791	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—liver cancer	1.79e-05	0.00079	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—liver cancer	1.79e-05	0.000788	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—liver cancer	1.77e-05	0.000781	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—liver cancer	1.76e-05	0.000778	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—liver cancer	1.76e-05	0.000776	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—liver cancer	1.74e-05	0.00077	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—liver cancer	1.72e-05	0.000759	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—liver cancer	1.7e-05	0.000753	CcSEcCtD
Daunorubicin—Pain—Epirubicin—liver cancer	1.69e-05	0.000747	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—liver cancer	1.69e-05	0.000747	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—liver cancer	1.67e-05	0.000736	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—liver cancer	1.65e-05	0.000731	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—liver cancer	1.63e-05	0.00072	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—liver cancer	1.63e-05	0.000719	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—liver cancer	1.63e-05	0.000718	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—liver cancer	1.62e-05	0.000714	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—liver cancer	1.59e-05	0.000702	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—liver cancer	1.58e-05	0.000696	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—liver cancer	1.57e-05	0.000693	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—liver cancer	1.56e-05	0.000691	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—liver cancer	1.56e-05	0.000691	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—liver cancer	1.56e-05	0.00069	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—liver cancer	1.56e-05	0.00069	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—liver cancer	1.51e-05	0.000666	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—liver cancer	1.5e-05	0.00066	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—liver cancer	1.46e-05	0.000643	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—liver cancer	1.45e-05	0.000642	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—liver cancer	1.45e-05	0.000639	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—liver cancer	1.45e-05	0.000639	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—liver cancer	1.42e-05	0.000626	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—liver cancer	1.4e-05	0.000618	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—liver cancer	1.35e-05	0.000597	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—liver cancer	1.35e-05	0.000595	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—liver cancer	1.31e-05	0.00058	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—liver cancer	1.31e-05	0.000577	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—liver cancer	1.29e-05	0.000571	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—liver cancer	1.26e-05	0.000555	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—liver cancer	1.25e-05	0.000553	CcSEcCtD
Daunorubicin—Rash—Epirubicin—liver cancer	1.25e-05	0.00055	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—liver cancer	1.25e-05	0.00055	CcSEcCtD
Daunorubicin—Headache—Epirubicin—liver cancer	1.24e-05	0.000547	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—liver cancer	1.21e-05	0.000534	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—liver cancer	1.17e-05	0.000519	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—liver cancer	1.16e-05	0.000514	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—liver cancer	1.15e-05	0.000509	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—liver cancer	1.15e-05	0.000509	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—liver cancer	1.15e-05	0.000506	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—liver cancer	1.09e-05	0.00048	CcSEcCtD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	1.61e-06	8.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.61e-06	8.55e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—liver cancer	1.6e-06	8.53e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYCS—liver cancer	1.6e-06	8.52e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	1.6e-06	8.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TAT—liver cancer	1.6e-06	8.49e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYCS—liver cancer	1.58e-06	8.43e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HMOX1—liver cancer	1.58e-06	8.41e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GGT1—liver cancer	1.57e-06	8.36e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GOT1—liver cancer	1.57e-06	8.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTHFR—liver cancer	1.56e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GOT1—liver cancer	1.56e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GGT1—liver cancer	1.56e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—liver cancer	1.55e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—liver cancer	1.55e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.54e-06	8.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.54e-06	8.18e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HMOX1—liver cancer	1.53e-06	8.14e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.53e-06	8.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTA4—liver cancer	1.53e-06	8.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.52e-06	8.1e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CB—liver cancer	1.51e-06	8.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HPGDS—liver cancer	1.5e-06	8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTA2—liver cancer	1.49e-06	7.92e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTM1—liver cancer	1.47e-06	7.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.46e-06	7.79e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CG—liver cancer	1.46e-06	7.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTA1—liver cancer	1.44e-06	7.64e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.44e-06	7.63e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTM1—liver cancer	1.43e-06	7.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.42e-06	7.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HPGDS—liver cancer	1.42e-06	7.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NAT2—liver cancer	1.42e-06	7.55e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.41e-06	7.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—liver cancer	1.41e-06	7.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GLUL—liver cancer	1.41e-06	7.48e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—liver cancer	1.41e-06	7.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CPT1B—liver cancer	1.41e-06	7.48e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A1—liver cancer	1.4e-06	7.43e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—liver cancer	1.4e-06	7.43e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HMOX1—liver cancer	1.39e-06	7.4e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HMOX1—liver cancer	1.38e-06	7.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALDOB—liver cancer	1.36e-06	7.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NR1H4—liver cancer	1.36e-06	7.21e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A1—liver cancer	1.35e-06	7.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSMD10—liver cancer	1.34e-06	7.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSMA4—liver cancer	1.34e-06	7.13e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTA3—liver cancer	1.33e-06	7.09e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.31e-06	6.96e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—liver cancer	1.31e-06	6.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GOT2—liver cancer	1.3e-06	6.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTHFR—liver cancer	1.3e-06	6.93e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CRABP1—liver cancer	1.3e-06	6.91e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.3e-06	6.91e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTM1—liver cancer	1.3e-06	6.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.29e-06	6.85e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTM1—liver cancer	1.28e-06	6.83e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CD—liver cancer	1.28e-06	6.81e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARA—liver cancer	1.28e-06	6.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.27e-06	6.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSMD10—liver cancer	1.27e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSMA4—liver cancer	1.27e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.27e-06	6.73e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—liver cancer	1.26e-06	6.73e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTHFR—liver cancer	1.26e-06	6.7e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARA—liver cancer	1.24e-06	6.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GOT2—liver cancer	1.23e-06	6.55e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A1—liver cancer	1.23e-06	6.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—liver cancer	1.23e-06	6.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2E1—liver cancer	1.23e-06	6.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTA4—liver cancer	1.22e-06	6.49e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A1—liver cancer	1.22e-06	6.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.19e-06	6.34e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTA2—liver cancer	1.19e-06	6.32e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2E1—liver cancer	1.16e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CD—liver cancer	1.15e-06	6.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.15e-06	6.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYCS—liver cancer	1.15e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTA1—liver cancer	1.15e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTHFR—liver cancer	1.15e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SERPINE1—liver cancer	1.14e-06	6.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HPGDS—liver cancer	1.14e-06	6.04e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTHFR—liver cancer	1.13e-06	6.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NAT2—liver cancer	1.13e-06	6.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GGT1—liver cancer	1.13e-06	5.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GOT1—liver cancer	1.13e-06	5.99e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARA—liver cancer	1.12e-06	5.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.12e-06	5.97e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CB—liver cancer	1.12e-06	5.94e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARA—liver cancer	1.11e-06	5.92e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.11e-06	5.91e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CG—liver cancer	1.09e-06	5.82e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.09e-06	5.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDOB—liver cancer	1.09e-06	5.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CPT1B—liver cancer	1.09e-06	5.77e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GLUL—liver cancer	1.09e-06	5.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYCS—liver cancer	1.08e-06	5.77e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.07e-06	5.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GOT1—liver cancer	1.06e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GGT1—liver cancer	1.06e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CG—liver cancer	1.06e-06	5.63e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—liver cancer	1.06e-06	5.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NR1H4—liver cancer	1.05e-06	5.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CRABP1—liver cancer	1.04e-06	5.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA3—liver cancer	1.03e-06	5.47e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RAF1—liver cancer	1.03e-06	5.46e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—liver cancer	1.02e-06	5.43e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSMD10—liver cancer	1.01e-06	5.38e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSMA4—liver cancer	1.01e-06	5.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—liver cancer	1.01e-06	5.38e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTOR—liver cancer	1e-06	5.33e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CB—liver cancer	1e-06	5.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—liver cancer	9.97e-07	5.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GOT2—liver cancer	9.84e-07	5.24e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	9.65e-07	5.13e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—liver cancer	9.63e-07	5.12e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—liver cancer	9.62e-07	5.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—liver cancer	9.56e-07	5.08e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—liver cancer	9.53e-07	5.07e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—liver cancer	9.5e-07	5.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—liver cancer	9.42e-07	5.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA4—liver cancer	9.41e-07	5.01e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—liver cancer	9.4e-07	5e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.34e-07	4.97e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—liver cancer	9.31e-07	4.95e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—liver cancer	9.3e-07	4.94e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—liver cancer	9.29e-07	4.94e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2E1—liver cancer	9.25e-07	4.92e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—liver cancer	9.23e-07	4.91e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—liver cancer	9.2e-07	4.89e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—liver cancer	9.19e-07	4.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA2—liver cancer	9.17e-07	4.88e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HPGDS—liver cancer	9.06e-07	4.82e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.01e-07	4.79e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—liver cancer	8.88e-07	4.72e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA1—liver cancer	8.85e-07	4.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—liver cancer	8.81e-07	4.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—liver cancer	8.78e-07	4.67e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAT2—liver cancer	8.75e-07	4.65e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	8.73e-07	4.64e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—liver cancer	8.67e-07	4.61e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYCS—liver cancer	8.66e-07	4.61e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GGT1—liver cancer	8.5e-07	4.52e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GOT1—liver cancer	8.5e-07	4.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—liver cancer	8.47e-07	4.5e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—liver cancer	8.39e-07	4.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDOB—liver cancer	8.39e-07	4.46e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—liver cancer	8.38e-07	4.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—liver cancer	8.36e-07	4.45e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—liver cancer	8.27e-07	4.4e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—liver cancer	8.21e-07	4.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.21e-07	4.36e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—liver cancer	8.11e-07	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.1e-07	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSMA4—liver cancer	8.08e-07	4.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSMD10—liver cancer	8.08e-07	4.3e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARA—liver cancer	8.06e-07	4.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CRABP1—liver cancer	8e-07	4.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GOT2—liver cancer	7.86e-07	4.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—liver cancer	7.76e-07	4.13e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—liver cancer	7.74e-07	4.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—liver cancer	7.63e-07	4.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARA—liver cancer	7.61e-07	4.05e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—liver cancer	7.54e-07	4.01e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—liver cancer	7.53e-07	4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2E1—liver cancer	7.39e-07	3.93e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—liver cancer	7.38e-07	3.93e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—liver cancer	7.3e-07	3.89e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—liver cancer	7.19e-07	3.83e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—liver cancer	7.17e-07	3.82e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.15e-07	3.8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—liver cancer	7.01e-07	3.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HPGDS—liver cancer	6.99e-07	3.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYCS—liver cancer	6.91e-07	3.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—liver cancer	6.9e-07	3.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.84e-07	3.64e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—liver cancer	6.81e-07	3.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GOT1—liver cancer	6.78e-07	3.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GGT1—liver cancer	6.78e-07	3.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—liver cancer	6.66e-07	3.54e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—liver cancer	6.65e-07	3.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—liver cancer	6.65e-07	3.53e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—liver cancer	6.52e-07	3.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—liver cancer	6.29e-07	3.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSMD10—liver cancer	6.23e-07	3.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSMA4—liver cancer	6.23e-07	3.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—liver cancer	6.2e-07	3.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—liver cancer	6.11e-07	3.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—liver cancer	6.09e-07	3.24e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARA—liver cancer	6.08e-07	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—liver cancer	6.07e-07	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GOT2—liver cancer	6.06e-07	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—liver cancer	6.01e-07	3.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—liver cancer	5.99e-07	3.19e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—liver cancer	5.73e-07	3.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2E1—liver cancer	5.7e-07	3.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—liver cancer	5.66e-07	3.01e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—liver cancer	5.65e-07	3e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—liver cancer	5.6e-07	2.98e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—liver cancer	5.56e-07	2.96e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—liver cancer	5.41e-07	2.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYCS—liver cancer	5.33e-07	2.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—liver cancer	5.31e-07	2.82e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—liver cancer	5.29e-07	2.81e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GOT1—liver cancer	5.23e-07	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GGT1—liver cancer	5.23e-07	2.78e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—liver cancer	5.21e-07	2.77e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—liver cancer	5.11e-07	2.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—liver cancer	5.03e-07	2.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—liver cancer	5e-07	2.66e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—liver cancer	4.99e-07	2.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—liver cancer	4.95e-07	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—liver cancer	4.95e-07	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARA—liver cancer	4.85e-07	2.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—liver cancer	4.7e-07	2.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—liver cancer	4.64e-07	2.47e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—liver cancer	4.58e-07	2.43e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—liver cancer	4.52e-07	2.4e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—liver cancer	4.5e-07	2.39e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—liver cancer	4.45e-07	2.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.36e-07	2.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—liver cancer	4.32e-07	2.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—liver cancer	4.18e-07	2.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—liver cancer	4.16e-07	2.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—liver cancer	4.1e-07	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—liver cancer	4.04e-07	2.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—liver cancer	4.01e-07	2.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—liver cancer	3.99e-07	2.12e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—liver cancer	3.82e-07	2.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARA—liver cancer	3.75e-07	1.99e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—liver cancer	3.68e-07	1.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—liver cancer	3.65e-07	1.94e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—liver cancer	3.64e-07	1.93e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—liver cancer	3.61e-07	1.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—liver cancer	3.22e-07	1.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—liver cancer	3.21e-07	1.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—liver cancer	3.19e-07	1.69e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—liver cancer	3.1e-07	1.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—liver cancer	3.05e-07	1.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—liver cancer	2.82e-07	1.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—liver cancer	2.78e-07	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—liver cancer	2.63e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—liver cancer	2.49e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—liver cancer	2.46e-07	1.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—liver cancer	2.43e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—liver cancer	1.99e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—liver cancer	1.94e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—liver cancer	1.59e-07	8.44e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—liver cancer	1.5e-07	7.97e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—liver cancer	1.22e-07	6.51e-06	CbGpPWpGaD
